Real-time enrollment status for this intestinal neoplasms clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 1:48 AM UTC
| NCT Number | NCT07222800 |
| Recruiting Status | Recruiting |
| Condition | Intestinal Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 200 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07222800 is currently recruiting participants. This phase3 study for intestinal neoplasms is actively seeking new participants at 200 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222800 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 200 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222800 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.